Bon Natural Life Limited · NASDAQ:BON
Bon Natural Life — FY2022 Earnings Presentation
16 slides from Bon Natural Life's earnings presentation, Feb 10, 2023
Slide 1: FY2022 Earnings Call Presentation
Bon Natural Life Limited (Nasdaq: Bon) FY2022 Earnings Call Presentation February 10, 2023 1
Slide 2: Confidentiality Note and Disclaimer
Confidentiality Note and Disclaimer This presentation may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements are characterized by future or conditional verbs such a
Slide 3: Management on Call
Management on Call Yongwei Hu Zhenchao Li Yingchun Xue Wenjuan Chen Chairman Chief Financial Officer Chief Operating Officer Chief Marketing Officer Chief Executive Officer 3
Slide 4: Agenda
Agenda • CEO Perspective • FY2022 Financials Overview • Questions & Answers 4
Slide 5: CEO Perspectives
Ss Bon Natural Life CEO Perspectives
Slide 6: Company Overview
Company Overview BON is one of the leading bio-ingredient solution providers in the natural, health and personal care industries, serving blue chip customers in both domestic China and overseas market. Raw materials are processed by BON to produce the Farm Sourced Raw Materials following three produ
Slide 7: Production Facilities & Capacities
Production Facilities & Capacities BON currently has 2 production facilities, and the third production site – the first phase of Yumen Plant is expected to commence around May 2023. Yumen Plant is expected to increase production capacity of fragrance compound and bioactive food ingredients by 200%
Slide 8: Proprietary Product Development
Proprietary Product Development FeatherPure – woman’s personal care gel Regulate microbial balance of female productive system Anti-bacterial and anti-inflammatory Cruciferous vegetable based probiotic powder drink Inhibit proliferation of Helicobacter pylori, a bacteria that causes digestive
Slide 9: Growth Strategies
Growth Strategies Capital Market Global Operation Instruments Expansion Business Strategy Carry out 2-3 merger and Looking for business acquisition to improve expansion opportunities in biomanufacturing capability the U.S., Japan, Europe, and and expand sales network Southeast Asia B2B Side B2C Side
Slide 10: FY2022 Financials Overview
FY2022 Financials Overview 10
Slide 11: Summary Financials
Summary Financials Strong growth driven by increase in average selling price, sales volume and number of customers. During the year ended September 30, 2022, sales increased to $29.9M, an increase of 17.3% over the same period in previous year. ― Increased average selling price of fragrance compou
Slide 12: Segment Growth
Segment Growth Segment Growth (FY2021 – FY2022) Fragrance Compounds (Millions) Bioactive Ingredients $13.7 $9.1M (30.3%) $12.7 Fragrance Compounds $13.7M (45.8%) 2021 2022 Health Supplements / Powder Drinks (Millions) Health Supplements + Powder Drinks $7.1 $7.1M (23.9%) $6.7 2021 2022 There was gro
Slide 13: Geographic Growth
Geographic Growth Revenues for Years Ended September 30, 2022 (by Geography) Geographical Sales Growth (For the Years Ended September 30, 2022) FY 2021 % of Total FY 2022 % of Total Overseas (Ex-PRC) $1.2M | (3.9%) China $23.7 93.0% $28.8 96.1% Overseas (Ex-PRC) $1.8 7.0% $1.2 3.9% Total $25.5 $29.9
Slide 14: Subsequent Events
Subsequent Events The company announced a delay of the commencement of Yumen Plant to May 2023. September 2022 The company closed a private offering of ordinary January 2023 shares and warrant for total subscription proceeds of $2,200,000. 14
Slide 15: Q&A
Q&A • To ask a question you may press * then 1 on your touch-tone phone. If you are using a speakerphone, please pick up your handset before pressing the keys. To withdraw your question please press * then 2. • For those on the webcast, You may submit questions by typing in the Submit a Question box
Slide 16: Bon Natural Life Limited (Nasdaq: Bon)
Bon Natural Life Limited (Nasdaq: Bon) FY2022 Earnings Call Presentation February 10, 2022 Principal Executive Offices: C601, Gazelle Valley, No.69 Jinye Road. Xi’an Hi-tech Zone, Xi’an, China 16